Please select your page

Commercialized Products - Rx

Impavido®

Impavido® (miltefosine) is indicated for the treatment of visceral and cutaneous Leishmaniasis and is currently approved in Germany, India, Israel and the U.S. (distributed by Profounda Inc. in the U.S.). For information relating to Impavido® (miltefosine) in the U.S., visit www.impavido.com.


Movantik®

Movantik® is indicated for opioid induced constipation. Movantik® is the first oral once-daily peripherally acting mu-opioid receptor antagonist (PAMORA) to be approved in Canada. For information relating to Movantik® in Canada, please contact Knight at 514-484-4483.

Buy now

You can now buy this awesome Joomla Theme directly on Themeforest for a really low price for this awesome and stunning Joomla product!

Nulla vitae elit libero, a pharetra augue. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam porta sem malesuada magna mollis euismod. Morbi leo risus, porta ac consectetur ac, vestibulum at eros. Nulla vitae elit libero, a pharetra augue.

BUY NOW ON THEMEFOREST

×

Login

Please login using your credentials recived by email when you register.

  or   Create an account

Forgot your password? |  Forgot your username?

×

Register now


I'm a small Introtext for the Register Module, I can be set in the Backend of the Joomla WS-Register Module.



  or   Login
×